Logo image of CBRE

CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

USA - NYSE:CBRE - US12504L1098 - Common Stock

155.47 USD
+0.05 (+0.03%)
Last: 10/17/2025, 10:02:09 AM
Fundamental Rating

5

CBRE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. CBRE has an average financial health and profitability rating. CBRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make CBRE suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CBRE was profitable.
CBRE had a positive operating cash flow in the past year.
In the past 5 years CBRE has always been profitable.
In the past 5 years CBRE always reported a positive cash flow from operatings.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.94%, CBRE belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
The Return On Equity of CBRE (13.21%) is better than 93.65% of its industry peers.
CBRE has a better Return On Invested Capital (6.77%) than 87.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 6.23%.
Industry RankSector Rank
ROA 3.94%
ROE 13.21%
ROIC 6.77%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CBRE has a Profit Margin of 2.86%. This is in the better half of the industry: CBRE outperforms 68.25% of its industry peers.
In the last couple of years the Profit Margin of CBRE has declined.
CBRE's Operating Margin of 4.26% is fine compared to the rest of the industry. CBRE outperforms 60.32% of its industry peers.
CBRE's Operating Margin has declined in the last couple of years.
The Gross Margin of CBRE (19.42%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 4.26%
PM (TTM) 2.86%
GM 19.42%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBRE is destroying value.
The number of shares outstanding for CBRE has been reduced compared to 1 year ago.
Compared to 5 years ago, CBRE has less shares outstanding
CBRE has a worse debt/assets ratio than last year.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CBRE has an Altman-Z score of 3.53. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
CBRE has a Altman-Z score of 3.53. This is in the better half of the industry: CBRE outperforms 77.78% of its industry peers.
CBRE has a debt to FCF ratio of 6.64. This is a slightly negative value and a sign of low solvency as CBRE would need 6.64 years to pay back of all of its debts.
CBRE's Debt to FCF ratio of 6.64 is fine compared to the rest of the industry. CBRE outperforms 71.43% of its industry peers.
CBRE has a Debt/Equity ratio of 0.88. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
CBRE has a Debt to Equity ratio (0.88) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 6.64
Altman-Z 3.53
ROIC/WACC0.75
WACC8.98%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.13 indicates that CBRE should not have too much problems paying its short term obligations.
With a Current ratio value of 1.13, CBRE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CBRE has a Quick Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CBRE (1.13) is worse than 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.95% over the past year.
Measured over the past 5 years, CBRE shows a small growth in Earnings Per Share. The EPS has been growing by 6.61% on average per year.
CBRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.96%.
CBRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.40% yearly.
EPS 1Y (TTM)50.95%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%46.91%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%16.24%

3.2 Future

CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.49% yearly.
The Revenue is expected to grow by 8.64% on average over the next years. This is quite good.
EPS Next Y23.08%
EPS Next 2Y20.41%
EPS Next 3Y19.23%
EPS Next 5Y18.49%
Revenue Next Year12.61%
Revenue Next 2Y11.35%
Revenue Next 3Y10.58%
Revenue Next 5Y8.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.91, which means the current valuation is very expensive for CBRE.
Compared to the rest of the industry, the Price/Earnings ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 74.60% of the companies listed in the same industry.
CBRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.29.
With a Price/Forward Earnings ratio of 20.98, CBRE is valued on the expensive side.
82.54% of the companies in the same industry are more expensive than CBRE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CBRE to the average of the S&P500 Index (22.85), we can say CBRE is valued inline with the index average.
Industry RankSector Rank
PE 27.91
Fwd PE 20.98
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CBRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 68.25% of the companies in the same industry.
CBRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 68.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.53
EV/EBITDA 21.14
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CBRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CBRE has a very decent profitability rating, which may justify a higher PE ratio.
CBRE's earnings are expected to grow with 19.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)4.22
EPS Next 2Y20.41%
EPS Next 3Y19.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CBRE GROUP INC - A

NYSE:CBRE (10/17/2025, 10:02:09 AM)

155.47

+0.05 (+0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners97.76%
Inst Owner Change-0.05%
Ins Owners0.52%
Ins Owner Change-0.05%
Market Cap46.26B
Analysts81.05
Price Target171.48 (10.3%)
Short Float %1.37%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.5%
Min EPS beat(2)8.58%
Max EPS beat(2)10.42%
EPS beat(4)4
Avg EPS beat(4)8.04%
Min EPS beat(4)2.25%
Max EPS beat(4)10.89%
EPS beat(8)8
Avg EPS beat(8)8.61%
EPS beat(12)11
Avg EPS beat(12)6.47%
EPS beat(16)14
Avg EPS beat(16)9.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.96%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)7
Avg Revenue beat(12)0.5%
Revenue beat(16)9
Avg Revenue beat(16)0.15%
PT rev (1m)0%
PT rev (3m)13.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.1%
EPS NY rev (1m)0.97%
EPS NY rev (3m)3.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 27.91
Fwd PE 20.98
P/S 1.21
P/FCF 41.53
P/OCF 32.49
P/B 5.61
P/tB N/A
EV/EBITDA 21.14
EPS(TTM)5.57
EY3.58%
EPS(NY)7.41
Fwd EY4.77%
FCF(TTM)3.74
FCFY2.41%
OCF(TTM)4.79
OCFY3.08%
SpS128.06
BVpS27.74
TBVpS-2.16
PEG (NY)1.21
PEG (5Y)4.22
Profitability
Industry RankSector Rank
ROA 3.94%
ROE 13.21%
ROCE 9.52%
ROIC 6.77%
ROICexc 7.28%
ROICexgc 14.04%
OM 4.26%
PM (TTM) 2.86%
GM 19.42%
FCFM 2.92%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexcg growth 3Y-10.49%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 6.64
Debt/EBITDA 3.11
Cap/Depr 43.42%
Cap/Sales 0.81%
Interest Coverage 3.6
Cash Conversion 60.88%
Profit Quality 102.2%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 3.53
F-Score6
WACC8.98%
ROIC/WACC0.75
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)50.95%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%46.91%
EPS Next Y23.08%
EPS Next 2Y20.41%
EPS Next 3Y19.23%
EPS Next 5Y18.49%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%16.24%
Revenue Next Year12.61%
Revenue Next 2Y11.35%
Revenue Next 3Y10.58%
Revenue Next 5Y8.64%
EBIT growth 1Y26.13%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year58.92%
EBIT Next 3Y25.82%
EBIT Next 5Y17.91%
FCF growth 1Y116.68%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y75.25%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%